High-sensitivity cardiac troponin T is more helpful in detecting peri-operative myocardial injury and apoptosis during coronary artery bypass graft surgery

Cardiovascular Journal of Africa

Volumn 26, Issue 6, 2015, Pages 234-241

  Kocak, Emel Fatma ^a   Altuntas, Irfan ^a   Kocak, Cengiz ^a   Aksoy, Ahmet ^a   Ozdomanic, Ibrahim Fevzi ^a   Isiklar, Ozden Ozben ^a   Akcilar, Raziye ^a   Unsal, Cevher ^a   Celenk, Merve ^a  

^a DUMLUPINAR UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Coronary artery bypass; Creatine kinase; MB form; Myocardial reperfusion injury; Troponin

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE MB; TROPONIN T; TNNT2 PROTEIN, HUMAN; TROPONIN I;

ADULT; ANGINA PECTORIS; AORTA CLAMPING; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART MUSCLE INJURY; HISTOPATHOLOGY; HUMAN; MALE; MEASUREMENT; PEROPERATIVE COMPLICATION; ADVERSE EFFECTS; AGED; BIOPSY; BLOOD; CARDIAC MUSCLE; CARDIOPULMONARY BYPASS; COMPARATIVE STUDY; ELECTIVE SURGERY; METABOLISM; MIDDLE AGED; MYOCARDIAL REPERFUSION INJURY; PATHOLOGY; PERIOPERATIVE PERIOD; PREDICTIVE VALUE; PROSPECTIVE STUDY; REPRODUCIBILITY; TIME FACTOR; UPREGULATION;

AGED; APOPTOSIS; BIOMARKERS; BIOPSY; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; CREATINE KINASE, MB FORM; ELECTIVE SURGICAL PROCEDURES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PERIOPERATIVE PERIOD; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; TIME FACTORS; TROPONIN I; TROPONIN T; UP-REGULATION;

EID: 84954524126     PISSN: 19951892     EISSN: None     Source Type: Journal    
DOI: 10.5830/CVJA-2015-052     Document Type: Article

References (38)

1. Nicolini F, Beghi C, Muscari C, Agostinelli A, Maria Budillon A, Spaggiari I, et al. Myocardial protection in adult cardiac surgery: current options and future challenges. Eur J Cardiothorac Surg 2003; 24: 986-993.
2. Malik V, Kale SC, Chowdhury UK, Ramakrishnan L, Chauhan S, Kiran U. Myocardial injury in coronary artery bypass grafting: on-pump versus off-pump comparison by measuring heart-type fatty-Acid-binding protein release. Tex Heart Inst J 2006; 33: 321-327.
3. Buckbcrg GD. Myocardial protection: entering the new millennium. J Card Surg 2002; 17: 447-450.
4. Yau TM, Weisel RD, Mickle DA, Komeda M, Ivanov J, Carson S, et al. Alternative techniques of cardioplegia. Circulation 1992; 86(Suppl 2): 377-384.
5. Benoit MO, Paris M, Silleran J, Fiemeyer A, Moatti N. Cardiac troponin I: its contribution to the diagnosis of perioperative myocardial infarction and various complications of cardiac surgery. Crit Care Med 2001; 29: 1880-1886.
6. Kovacevic' R, Majkid-Singh N, Ignjatovic' S, Otasevid P, Obrenovid R, Paris M, et al. Troponin T levels in detection of perioperative myocardial infarction after coronary artery bypass surgery. Clin Lab 2004; 50: 437-445.
7. Noora J, Ricci C, Hastings D, Hill S, Cybulsky I. Determination of troponin I release after CABG surgery./Card Surg 2005; 20: 129-135.
8. Motshabi P. Myocardial ischaemia during coronary artery bypass graft surgery: a review of the pathophysiology (Part I). South Afr J Anaesth Analg 2012; 18: 70-74.
9. Fischer UM, Tossios P, Huebner A, Geissler HJ, Bloch W, Mehlhorn U. Myocardial apoptosis prevention by radical scavenging in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 2004; 128: 103-108.
10. Ramlawi B, Feng J, Mieno S, Szabo C, Zsengeller Z, Clements R, et al. Indices of apoptosis activation after blood cardioplegia and cardiopulmonary bypass.Circulation 2006; 114 (1 Suppl): 1257-1263.
11. Di Stefano S, Casquero E, Bustamante R, Gualis J, Carrascal Y, Bustamante J, el al. Plasma troponins as markers of myocardial damage during cardiac surgery with extracorporeal circulation. Tohoku J Exp Med 2007; 213: 63-69.
12. Qing M, Vazquez-Jimenez JF, Klosterhalfen B, Sigler M, Schumacher K, Duchateau J, et al. Influence of temperature during cardiopulmonary bypass on leukocyte activation, cytokine balance, and post-operative organ damage. Shock 2001; 15: 372-377.
13. Ong SC, Lim SG, Li SC. Reliability and validity of a Chinese version's health-related quality of life questionnaire for hepatitis B patients. Value Health 2010; 13: 324-327.
14. Preeshagul I, Gharbaran R, Jeong KH, Abdel-Razek A, Lee LY, Elman E, et al. Potential biomarkers for predicting outcomes in CABG cardio-thoracic surgeries. J Cardiothorac Surg 2013; 18: 176.
15. Koniari I, Koletti B, Apostolakis E. Perioperative myocardial infarction following coronary artery bypass grafting. Interact Cardiovasc Thorac Surg 2011; 12: 599.
16. Berkan O, Sagban M. Sialic acid or troponin T to detect perioperative myocardial damage in patients undergoing elective coronary artery bypass grafting. Circ J 2002; 66: 1019-1023.
17. Jaffe AS, Babuin L, Apple FS. Biomarkers in acute cardiac disease: the present and the future. J Am Coll Cardiol 2006; 48: 1-11.
18. Peivandi AA, Dahm M, Opfermann UT, Peetz D, Doerr F, Loos A, et al. Comparison of cardiac troponin I versus T and creatine kinase MB after coronary artery bypass grafting in patients with and without perioperative myocardial infarction. Herz 2004; 29: 658-664.
19. Gill C, Mestril R, Samali A. Losing heart: the role of apoptosis in heart disease-A novel therapeutic target FASEB J 2002; 16: 135-46.
20. Anselmi A, Abbate A, Girola F, Nasso G, Biondi-Zoccai GG, Possati G, et al. Myocardial ischemia, stunning, inflammation, and apoptosis during cardiac surgery: a review of evidence. Eur J Cardiothorac Surg 2004; 25: 304-311.
21. Fischer UM, Cox CS Jr, Laine GA, Mehlhorn U, Bloch W, Allen SJ. Induction of cardioplcgic arrest immediately activates the myocardial apoptosis signal pathway. Am J Physiol Heart Circ Physiol 2007; 292: H1630-1633.
22. Poulsen TD, Andersen LW, Steinbruchel D, Gotze JP, Jorgensen OS, Olsen NV. Two large preoperative doses of erythropoietin do not reduce the systemic inflammatory response to cardiac surgery. J Cardiothorac Vase Anesth 2008; 23: 316-323.
23. Yeh CH, Wang YC, Wu YC, Chu JJ, Lin PJ. Continuous tepid blood cardioplegia can preserve coronary endothelium and ameliorate the occurrence of cardiomyocyte apoptosis. Chest 2003; 123: 1647-1654.
24. Yeh CH, Lin YM, Wu YC, Lin PJ. Inhibition of NF-kappa B activation can attenuate ischemia/reperfusion-induced contractility impairment via decreasing cardiomyocytic proinflammatory gene up-regulation and matrix metalloproteinase expression. J Cardiovasc Pharmacol 2005; 45: 301-309.
25. Schmitt JP, Schroder J, Schunkert H, Birnbaum DE, Aebert H. Role of apoptosis in myocardial stunning after open-heart surgery. Ann Thorac Surg 2002; 73: 1229-1235.
26. Ruifrok WT, Westenbrink BD, de Boer RA, den Hamer IJ, Erasmus ME, Mungroop HE, et al. Apoptosis during CABG surgery with the use of cardiopulmonary bypass is prominent in ventricular but not in atrial myocardium. Neth Heart J 2010; 18: 236-242.
27. Wu ZK, Laurikka J, Saraste A, Kyto V, Pehkonen EJ, Savunen T, et al. Cardiomyocyte apoptosis and ischemic preconditioning in open heart operations. Ann Thorac Surg 2003; 76: 528-534.
28. Nigam PK. Biochemical markers of myocardial injury. Indian J Clin Biochem 2007; 22: 10-17.
29. Bleier J, Vorderwinkler KP, Falkensammer J, Mair P, Dapunt O, Puschendorf B, et al. Different intracellular compartmentations of cardiac troponins and myosin heavy chains: a causal connection to their different early release after myocardial damage. Clin Client 1998; 44: 1912-1918.
30. Koh TW, Hooper J, Kemp M, Ferdinand FD, Gibson DG, Pepper JR. Intraoperative release of troponin T in coronary venous and arterial blood and its relation to recovery of left ventricular function and oxidative metabolism following coronary artery surgery. Heart 1998; 80: 341-348.
31. Takeda S, Nakanishi K, Ikezaki H, Kim C, Sakamoto A, Tanaka K, et al. Cardiac marker responses to coronary artery bypass graft surgery with cardiopulmonary bypass and aortic cross-clamping. J Cardiothorac Vase Anesth 2002; 16: 421-125.
32. Bignami E, Landoni G, Crescenzi G, Gonfalini M, Bruno G, Pappalardo F, et al. Role of cardiac biomarkers (troponin I and CK-MB) as predic-tors of quality of life and long-term outcome after cardiac surgery. Ann CardAnaesth 2009; 12: 22-26.
33. Thielmann M, Massoudy P, Marggraf G, Knipp S, Schmermund A, Piotrowski J, et al. Role of troponin I, myoglobin, and creatine kinase for the detection of early graft failure following coronary artery bypass grafting. Eur J Cardiothorac Surg 2004; 26: 102-109.
34. Tzimas PG, Milionis HJ, Arnaoutoglou HM, Kalantzi KJ, Pappas K, Karfis E. et al. Cardiac troponin I versus creatine kinase-MB in the detection of postoperative cardiac events after coronary artery bypass grafting surgery. J Cardiovasc Surg 2008; 49: 95-101.
35. Apple FS and Collinson PO. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem 2012; 58: 54-61.
36. Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 2010; 56: 254-261.
37. Wang TK, Stewart RA, Ramanathan T, Kang N, Gamble G, White HD. Diagnosis of MI after CABG with high-sensitivity troponin T and new ECG or echocardiogram changes: relationship with mortality and validation of the universal definition of MI. Eur Heart J Acute Cardiovasc Care 2013; 2: 323-333.
38. Nagele P, Brown F, Gage BF, Gibson DW, Miller JP, Jaffe AS, et al. High-sensitivity cardiac troponin T in prediction and diagnosis of myocardial infarction and long-term mortality after noncardiac surgery. Am Heart J 2013; 166: 325-332.